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The ability of the Lyme disease spirochetes to establish an infection in mammals is dependent in part on
proteins of tick origin. Schuijt et al. (2011) investigate the role of the tick-derived protein, TSLPI, in spirochete
transmission and in the evasion of killing by the lectin complement pathway.The nutritional requirements of ticks can
be satisfied only through the ingestion of
a blood meal from a vertebrate host. The
molecular interplay between ticks and
their blood source at the tick bite site
has evolved over 100 million years (Mans
et al., 2002). Ticks have masterfully adap-
ted through the production of salivary
proteinswith anti-inflammatory, anticoag-
ulant, anticomplement, or immunomodu-
latory activities (Francischetti et al.,
2009). Tick bites are generally not painful,
and ticks in and of themselves do not
pose significant health threats to humans.
So why then does the mere thought of
feeding ticks raise such apprehension
and concern? The reason is that ticks
are vectors of diverse bacterial, viral,
and protozoan pathogens that can cause
serious and in some cases potentially fatal
infections in humans.
Lyme disease, a debilitating and persis-
tent bacterial infection caused by Borrelia
burgdorferi, B. garinii, and B. afzelii, is the
most prevalent tick-borne disease in Eu-
rope and North America (Benach et al.,
1983; Burgdorfer et al., 1982). The Lyme
borrelia are maintained in an enzootic
cycle involving Ixodes ticks and diverse
vertebrate hosts including mammals,
birds, and reptiles. Since transovarial
transmission of the Lyme borrelia in ticks
does not occur, population maintenance
is strictly dependent on animal reservoirs.
As the Borrelia transit from ticks to hosts,
they must circumvent innate immune
defenses including complement. While
the Borrelia activate both the classical
and alternative complement pathways,
some species, such as B. burgdorferi,
are highly resistant to complement-medi-
ated killing (Zipfel et al., 2008). Evasion
of the human alternative complementpathway has been demonstrated to be
mediated by the binding of factor H (FH),
a negative regulator of the alternative
complement pathway. It inhibits assem-
bly of the C3 convertase complex, accel-
erates decay of preformed complex, and
serves as a cofactor for factor I-mediated
cleavage of C3b. Borrelia species such as
B. garinii that do not bind FH (McDowell
et al., 2003) are highly sensitive to human
complement (at least in vitro). However,
since B. garinii is maintained in vertebrate
hosts, it must be capable of complement
evasion to some degree.
In an intriguing study, Schuijt and
colleagues extend earlier analyses of the
I. scapularis tick salivary lectin pathway
inhibitor (TSLPI) protein (previously re-
ferred to as P8). rTSLPI had previously
been demonstrated in vitro to convey
protection to B. garinii against comple-
ment-mediated killing (Schuijt et al.,
2011). In the current study, the authors
sought to define the molecular basis of
TSLPI-mediated protection. In an ex-
tended series of experiments, it is demon-
strated that rTSLPI inhibits membrane
attack complex, protects against anti-
body-mediated complement destruction,
inhibits phagocytosis of Borrelia by
neutrophils, and attenuates Borrelia-
induced neutrophil chemotactic re-
sponses. Based on the inability of rTSLPI
to inhibit erythrocyte lysis by human
complement, the authors speculated that
TSLPI interfaces with the lectin comple-
ment pathway. Consistent with this, incu-
bation of serum with rTSLPI decreased
C4 deposition on mannan in a dose-
dependent manner. Subsequent studies
revealed that rTSLPI inhibits lectin
pathway complement activation by dis-
rupting interactions between MBL and itsCell Host & Microbe 1ligand. Lastly, the potential influence of
rTSLPI on in vivo spirochete transmission
was assessed through RNAi silencing.
RNAi silencing of TSLPI expression in in-
fected ticks resulted in the detection of
fewer spirochetes in the skin, heart, and
joints. In addition, passive immunization
of mice with serum from rabbits vacci-
nated with rTSLPI reduced the efficiency
of spirochete transmission to mice and
acquisition by ticks.
Based on the collective analyses sum-
marized above, Schuijt and colleagues
conclude that a crucial role of the lectin
complement pathway in the eradication
of the causative agent of Lyme disease
has been demonstrated and that the
I. scapularis TSLPI protein serves to abate
complement activation on B. burgdorferi
sensu lato by impairing the lectin com-
plement pathway. Indeed, compelling
evidence is provided in support of these
conclusions. However, there is room for
alternative interpretation, and there are
additional questions that remain to be
answered. Previous studies have clearly
demonstrated the importance of the
classical and alternative complement
pathways in the control of Borrelia infec-
tions, and it is increasingly clear that the
interplay between complement pathways
is complex and not yet fully deciphered.
Furthermore, significant differences in
the complement evasion strategies and
pathways of B. garinii and B. burgdorferi
have been clearly defined. It remains
to be determined if data obtained with
one species can in fact be extrapo-
lated to another. Unfortunately, tick-host
models for B. garinii infections are less
well developed, and there are technical
challenges that preclude the same
level of analyses that have been directed0, August 18, 2011 ª2011 Elsevier Inc. 95
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Borrelia-produced ligands that would
directly interact with mannose-binding
lectin or ficolins have not been identified.
The identification of such ligands and the
demonstration of their ability to directly
activate the lectin pathway would be
a significant step forward in dissecting
the role of the lectin pathway in Borrelia
biology. Another important question to
consider is how TSLPI might influence,
as reported in this study, the spirochetal
burden at sites distal to the tick bite site.
Since the amount of TSLPI produced by
a feeding tick would be low, and since it
does not bind directly to spirochetes, its
influence on complement activity would
most certainly be confined to the tick
bite site. Lastly, the possibility exists that
the influence of TSLPI on the transmission
and acquisition of Borrelia is not unique to
the Lyme disease spirochetes. Interest-96 Cell Host & Microbe 10, August 18, 2011 ªingly, through BLAST searches, we noted
the existence of genes that encode TSLPI
homologs in the genomes of diverse
tick genera including Ixodes, Argas,
Rhipicephalus, and Ornithodoros. These
TSLPI-related genes most likely are de-
rived from a common ancestral gene
that existed prior to the divergence of
tick genera. Future analyses of the po-
tential role of TSLPI homologs in diverse
ticks and assessment of their influence
on the transmission of other tick-borne
pathogens will provide important insight
into the role of this interesting tick sali-
vary protein in tick-host-pathogen
interactions.
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